Point72 Middle East FZE’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-190,823	Closed	-$635K	–	181
2023 Q4	$635K	Buy	+190,823	New	+$635K	0.02%	359
2023 Q3	–	Sell	-54,500	Closed	-$233K	–	977
2023 Q2	$233K	Buy	54,500 +53,044	+3,643%	+$226K	0.01%	561
2023 Q1	$9.96K	Buy	+1,456	New	+$9.96K	﹤0.01%	936